Health & Environmental Research Online (HERO)


Print Feedback Export to File
203881 
Journal Article 
Hypertension in rheumatoid arthritis.[erratum appears in Rheumatology (Oxford). 2009 Apr;48(4):458] 
Panoulas, VF; Metsios, GS; Pace, AV; John, H; Treharne, GJ; Banks, MJ; Kitas, GD 
2008 
1 
Rheumatology
ISSN: 1462-0324
EISSN: 1462-0332 
OXFORD UNIV PRESS 
OXFORD 
47 
9 
1286-1298 
English 
18467370 
WOS:000258960600007 
RA associates with an increased burden of cardiovascular disease, which is at least partially attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly prevalent, and seems to be under-diagnosed and under-treated among patients with RA. In this review, we discuss the mechanisms that may lead to increased blood pressure in such patients, paying particular attention to commonly used drugs for the treatment of RA. We also suggest screening strategies and management algorithms for HT, specific to the RA population, although it is clear that these need to be formally assessed in prospective randomized controlled trials designed specifically for the purpose, which, unfortunately, are currently lacking. [References: 259] 
Anti-Inflammatory Agents, Non-Steroidal/ae [Adverse Effects]; Antihypertensive Agents/tu [Therapeutic Use]; *Arthritis, Rheumatoid/co [Complications]; Glucocorticoids/ae [Adverse Effects]; Humans; Hypertension/dt [Drug Therapy]; *Hypertension/et [Etiology]; Inflammation/co [Complications]; Motor Activity; Risk Factors; 0 (Anti-Inflammatory Agents, Non-Steroidal); 0 (Antihypertensive Agents); 0 (Glucocorticoids)